Summary
The levels of five neuropeptides (substance-P, somatostatin, cholecystokinin octapeptide, methionin-enkephalin and dynorphin) were examined in the brain and the spinal cord of rats 2 weeks after intracerebroventricular injection of 5,7-dihydroxytryptamine (5,7-DHT). 5,7-DHT injection caused a significant reduction of the serotonin level in all regions of the brain. The level of each neuropeptide except dynorphin significantly increased in specific regions of the brain after 5,7-DHT treatment without any decrease in their levels in any region. Since, coexistence and interaction between classical neurotransmitters and neuropeptides in the same neurons have been reported, both are indispensable for evaluating pathophysiological state of the brain function associated with abnormal neural transmission. The present findings together with previous reports suggest that neuropeptides act as neurotransmitters and compensate for the impaired function of the serotonergic systems.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baumgarten HG, Björklund A, Lachenmayer I, Nobin A (1973) Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurons in the rat CNS. Acta Physiol Scand [Suppl] 391: 1–19
Curzon G, Green AR (1970) Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol 39: 653–655
Dellavedova L, Parenti M, Tirone F, Gropetti A (1982) Interactions between serotonergic and encephalinergic neurons in rat striatum and hypothalamus. Eur J Pharmacol 85: 29–34
Emson PC, Gilbert RFT, Bennet GW, Marsden CA, Hunt SP (1983) The coexistence of thyrotropin-releasing hormone and substance P in bulbospinal serotonergic neurons. In: Griffiths EC, Bennet GW (eds) Thyrotropin-releasing hormone. Raven Press, New York, pp 33–43
Fekete M, Kadar T, Penke B, Kovacs K, Telegdy G (1981) Influence of cholecystokinin octapeptide sulfate ester on brain monoamine metabolism in rats. J Neural Transm 50: 81–88
Garcia-Sevilla JA, Magnusson T, Carlsson A (1978) Effects of intracerebroventricularly administered somatostatin on brain monoamine turnover. Brain Res 155: 159–164
Grobecker H (1983) Transmitter-peptide coexistence in the central nervous system. Eur Neurol [Suppl 22]: 38–46
Harro J, Lang A, Vasar E (1990) Long-term diazepam treatment produces change in cholecystokinin receptor binding in rat brain. Eur J Pharmacol 180: 77–83
Hökfelt T, Johanson O, Ljungdhal Å, Lundberg JM, Schultzberg M (1980) Peptidergic neurones. Nature 284: 515–521
Kurumaji A, Mitushio H, Takashima M (1988) Chronic dietary treatment with antide-pressants decrease brain Met-enkephalin-like immunoreactivity in the rat. Psychopharmacology 94: 188–192
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Mantyh PW, Hunt SP (1984) Evidence for cholecystokinin-like neurons in the rat medulla oblongata which project to the spinal cord. Brain Res 291: 49–54
Mashal RD, Owen F, Deakin JF, Poulter M (1983) The effects of cholecystokinin on dopaminergic mechanisms in the rat striatum. Brain Res 277: 375–376
Ogawa N, Tompson T, Friesen HG, Martin JB, Brazeau P (1977) Properties of soluble somatostatin-binding protein. Biochem J 165: 269–277
Ogawa N (1985 a) Neuropeptides and their receptors in aged-rat brain. Acta Med Okayama 39: 315–319
Ogawa N, Kabuto H, Hirose Y, Nukina I, Mori A (1985 b) Up-regulation of thyrotropin-releasing hormone (TRH) receptors in rat spinal cord after codepletion of serotonin and TRH. Regul Pept 10: 85–90
Ogawa N, Hirose Y, Nomura M (1986) Biochemical and functional aspects of neuropeptides and their receptors in aged-rat brain. In: Yoshida H (ed) Recent research on neurotransmitter receptors. Excerpta Medica, Amsterdam, pp 56–68
Palletier G, Steinbusch HW, Verhofstad A (1981) Immunoreactive substance P and serotonin present in the same dense core vesicles. Nature (Lond) 293: 71–72
Paolo P, Maurizio R (1991) Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens. Br J Pharmacol 103: 1790–1794
Pongdohana K, Ogawa N, Hirose Y, Ono T, Kosaka F, Mori A (1987) Effects of ketamine on the cholecystokinin, somatostatin, substance P and thyrotropin-releasing hormone in discrete regions of rat brain. Neurochem Res 12: 73–77
Starr MS, James TA, Gaytten D (1978) Behavioral depressant and antinociceptive properties of substance P in the mouse. Eur J Pharmacol 48: 203–212
Tang F, Costa E, Schwaltz JP (1983) Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc Natl Acad Sci USA 80: 3841–3844
Tanaka S, Tsujimoto A (1981) Somatostatin facilitates the serotonin release from rat cerebral cortex, hippocampus and hypothalamus slices. Brain Res 208: 219–222
van Loon GR, de Souza EB (1978) Effects of beta-endorphin on brain serotonin metabolism. Life Sci 23: 971–978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kondo, Y., Ogawa, N., Asanuma, M. et al. Regional changes in neuropeptide levels after 5,7-dihydroxytryptamine-induced serotonin depletion in the rat brain. J. Neural Transmission 92, 151–157 (1993). https://doi.org/10.1007/BF01244874
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01244874